Register for free to listen to this article
Listen with Speechify
0:00
1:00
SRU Biosystems 
 
SRU Biosystems recently announced the extension of itsproduct line of label-free instrumentation and biosensors with the introductionof its BIND Scanner, a plate-based, label-free instrument capable of monitoringcellular responses at an individual cell resolution. The BIND Scanner has acompact design that allows it to be placed in a cell incubator to run assays at37 degrees C and high humidity. Using new, modified microplate-based photoniccrystal biosensors, it can locate and track individual live cells withuser-controlled resolution (variable from 2 mm to 3.75 microns). It continuouslymonitors cell adhesion and morphological changes in real-time, allowing assaysto be run using small populations of cells, or even single cells. BINDbiosensor microplates are compatible with standard fixation and stainingtechniques, including fluorescence applications, allowing orthogonalinformation to be gathered by the user. The BIND system supports the use of 8-,16-, 96-, 384-, and 1,536-well microplates using the company's opticalbiosensor technology. 
 
SRU Biosystems 
www.srubiosystems.com
(781) 933-7255
 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Clear cells with round, blue centers are shown against a varied blue background

Supercharging cell line development and engineering with automated single cell sorting

Researchers can enhance efficiency, yield, and consistency in clonal cell line development with specialized tools.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue